In contrast to simple blood lipid measurements, our study focuses on lipoprotein lipase (LPL) agonists, which dynamically regulate lipid metabolism and inflammation, offering a more comprehensive perspective on their potential protective role in AF. Here, LPL is linked to atrial fibrillation.